SKIN BARRIER SUN SHIELD SPF 30

SKIN BARRIER SUN SHIELD SPF 30 was reported 141 times

SKIN BARRIER SUN SHIELD SPF 30 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL MELANOSIS 1 0.0182
1 PINGUECULA 1 0.0094
2 EXPOSURE TO MOULD 1 0.0079
3 APPLICATION SITE NODULE 1 0.0073
4 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
5 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
6 XEROSIS 5 0.0040
7 LENTIGO 2 0.0040
8 SOLAR DERMATITIS 1 0.0037
9 CHEMICAL BURNS OF EYE 1 0.0036
10 PYOGENIC GRANULOMA 1 0.0021
11 HYPEREOSINOPHILIC SYNDROME 1 0.0018
12 APPLICATION SITE DISCHARGE 2 0.0017
13 FUNGAL OESOPHAGITIS 1 0.0014
14 SEBORRHOEIC KERATOSIS 2 0.0014
15 GUTTATE PSORIASIS 1 0.0012
16 SUNBURN 9 0.0012
17 MILIARIA 2 0.0012
18 INJECTION SITE DRYNESS 1 0.0011
19 C-REACTIVE PROTEIN 1 0.0011
20 FACIAL ASYMMETRY 1 0.0010
21 IMMUNE-MEDIATED HEPATITIS 2 0.0010
22 CHEMICAL BURN 1 0.0009
23 MALIGNANT MELANOMA IN SITU 1 0.0008
24 JOINT WARMTH 1 0.0008
25 SKIN DEPIGMENTATION 1 0.0007
26 MENINGITIS VIRAL 1 0.0007
27 VASCULAR INJURY 1 0.0007
28 CONJUNCTIVITIS ALLERGIC 1 0.0007
29 ACNE CYSTIC 2 0.0007
30 SEBORRHOEIC DERMATITIS 1 0.0006
31 ARTHROPOD STING 1 0.0006
32 MALIGNANT MELANOMA 8 0.0006
33 CHEILITIS 3 0.0006
34 NASAL OEDEMA 1 0.0006
35 APPLICATION SITE DISCOLOURATION 2 0.0005
36 DERMATITIS PSORIASIFORM 1 0.0005
37 PIGMENTATION DISORDER 3 0.0005
38 APPLICATION SITE EXFOLIATION 2 0.0005
39 WALKING DISABILITY 1 0.0005
40 APPLICATION SITE SCAB 1 0.0005
41 MELANOCYTIC NAEVUS 2 0.0005
42 METASTATIC MALIGNANT MELANOMA 1 0.0004
43 HAEMANGIOMA 1 0.0004
44 VITILIGO 1 0.0004
45 EYE OEDEMA 1 0.0004
46 SENSITIVE SKIN 3 0.0004
47 ACTINIC KERATOSIS 1 0.0004
48 SKIN DISCOMFORT 1 0.0004
49 APPLICATION SITE HAEMORRHAGE 1 0.0004
50 PHOTOSENSITIVITY REACTION 6 0.0004
51 RED BLOOD CELL COUNT INCREASED 1 0.0004
52 VITREOUS HAEMORRHAGE 1 0.0004
53 CHOLECYSTITIS ACUTE 2 0.0004
54 SKIN HYPERPIGMENTATION 3 0.0003
55 SKIN WARM 2 0.0003
56 TONGUE ULCERATION 1 0.0003
57 ABNORMAL LOSS OF WEIGHT 2 0.0003
58 DERMATITIS 6 0.0003
59 SCLERODERMA 1 0.0003
60 INTENTIONAL UNDERDOSE 2 0.0003
61 OESOPHAGEAL ULCER 1 0.0003
62 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
63 BASAL CELL CARCINOMA 4 0.0003
64 MIOSIS 2 0.0002
65 TRIGGER FINGER 1 0.0002
66 SELF-INJURIOUS IDEATION 1 0.0002
67 OCULAR ICTERUS 1 0.0002
68 APPLICATION SITE ERYTHEMA 6 0.0002
69 SKIN TIGHTNESS 1 0.0002
70 SQUAMOUS CELL CARCINOMA 2 0.0002
71 ENDOMETRIOSIS 1 0.0002
72 INCORRECT DOSAGE ADMINISTERED 1 0.0002
73 ORGANISING PNEUMONIA 1 0.0002
74 APPLICATION SITE SWELLING 1 0.0002
75 AMMONIA INCREASED 1 0.0002
76 ANAL FISTULA 1 0.0002
77 APPLICATION SITE PAIN 4 0.0002
78 HYPERKERATOSIS 1 0.0002
79 ANGIOPATHY 1 0.0002
80 ACUTE PULMONARY OEDEMA 1 0.0002
81 SKIN ATROPHY 1 0.0002
82 RALES 1 0.0002
83 HYPERTRIGLYCERIDAEMIA 1 0.0002
84 CATARACT OPERATION 1 0.0002
85 PRE-EXISTING CONDITION IMPROVED 1 0.0002
86 APPLICATION SITE VESICLES 1 0.0002
87 IMMUNE SYSTEM DISORDER 2 0.0002
88 SKIN MASS 1 0.0001
89 PAIN OF SKIN 4 0.0001
90 DROOLING 1 0.0001
91 ENCEPHALITIS 1 0.0001
92 RETINAL HAEMORRHAGE 1 0.0001
93 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
94 SKIN HAEMORRHAGE 2 0.0001
95 ACNE 10 0.0001
96 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
97 PULMONARY HAEMORRHAGE 1 0.0001
98 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
99 MUSCLE DISORDER 1 0.0001
100 HYPERAESTHESIA 1 0.0001
101 SKIN PLAQUE 1 0.0001
102 CARDIAC MURMUR 1 0.0001
103 NAIL DISORDER 1 0.0001
104 BLOOD CALCIUM INCREASED 1 0.0001
105 IMMUNOSUPPRESSION 1 0.0001
106 LIP DRY 1 0.0001
107 MOOD ALTERED 3 0.0001
108 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
109 SPINAL DISORDER 1 0.0001
110 CHOLESTASIS 2 0.0001
111 PETECHIAE 1 0.0001
112 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
113 SCRATCH 1 0.0001
114 SWELLING FACE 6 0.0001
115 ASPIRATION 1 0.0001
116 NERVE INJURY 1 0.0001
117 RASH PAPULAR 2 0.0001
118 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
119 BLISTER 5 0.0001
120 DERMATITIS CONTACT 1 0.0001
121 SCAB 1 0.0001
122 VASCULITIS 1 0.0001
123 CARDIOMEGALY 1 0.0001
124 APPLICATION SITE IRRITATION 1 0.0001
125 HAIR COLOUR CHANGES 1 0.0001
126 DRY EYE 4 0.0001
127 NODULE 1 0.0001
128 ECZEMA 4 0.0001
129 INCORRECT PRODUCT STORAGE 1 0.0001
130 TACHYPNOEA 1 0.0001
131 SKIN LESION 2 0.0001
132 APPLICATION SITE RASH 1 0.0001
133 SKIN REACTION 1 0.0001
134 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
135 BRONCHOSPASM 1 0.0001
136 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
137 SKIN IRRITATION 3 0.0001
138 SKIN DISCOLOURATION 3 0.0001
139 RASH ERYTHEMATOUS 3 0.0001
140 BACK DISORDER 1 0.0001
141 DRY SKIN 8 0.0001
142 SKIN EXFOLIATION 5 0.0001
143 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
144 SCAR 1 0.0001
145 MUSCULOSKELETAL DISCOMFORT 1 0.0001
146 RASH MACULAR 2 0.0001
147 THIRST 1 0.0001
148 SKIN BURNING SENSATION 4 0.0001
149 GASTROENTERITIS VIRAL 1 0.0001
150 OSTEOMYELITIS 1 0.0001
151 BACTERIAL INFECTION 1 0.0001
152 GASTRIC ULCER 1 0.0001
153 DISABILITY 1 0.0001
154 PSORIATIC ARTHROPATHY 2 0.0000
155 INJURY ASSOCIATED WITH DEVICE 1 0.0000
156 LUNG NEOPLASM MALIGNANT 2 0.0000
157 MOUTH ULCERATION 1 0.0000
158 LIVER FUNCTION TEST INCREASED 1 0.0000
159 SKIN CANCER 1 0.0000
160 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
161 RASH MACULO-PAPULAR 1 0.0000
162 GLOSSODYNIA 1 0.0000
163 APPLICATION SITE PRURITUS 1 0.0000
164 ERYTHEMA 9 0.0000
165 BURNING SENSATION 3 0.0000
166 UNDERDOSE 3 0.0000
167 HYPOPHAGIA 1 0.0000
168 HEPATITIS 1 0.0000
169 INFLAMMATION 2 0.0000
170 PSORIASIS 5 0.0000
171 JAUNDICE 1 0.0000
172 FREQUENT BOWEL MOVEMENTS 1 0.0000
173 WOUND 1 0.0000
174 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
175 EYE PAIN 2 0.0000
176 INTENTIONAL DOSE OMISSION 1 0.0000
177 HYPERSOMNIA 1 0.0000
178 EYE IRRITATION 2 0.0000
179 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
180 INTENTIONAL PRODUCT MISUSE 3 0.0000
181 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
182 ASCITES 1 0.0000
183 PSYCHOTIC DISORDER 1 0.0000
184 URINARY INCONTINENCE 1 0.0000
185 RESPIRATORY DISORDER 1 0.0000
186 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
187 RASH 14 0.0000
188 HEART RATE INCREASED 3 0.0000
189 EXPIRED PRODUCT ADMINISTERED 1 0.0000
190 SKIN DISORDER 1 0.0000
191 URINARY RETENTION 1 0.0000
192 TYPE 2 DIABETES MELLITUS 1 0.0000
193 HAEMATURIA 1 0.0000
194 ILLNESS 3 0.0000
195 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
196 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
197 MYELOSUPPRESSION 1 0.0000
198 DRUG EFFECT INCOMPLETE 1 0.0000
199 HYPERGLYCAEMIA 1 0.0000
200 INJECTION SITE MASS 1 0.0000
201 PRODUCT USE ISSUE 5 0.0000
202 DYSPNOEA EXERTIONAL 1 0.0000
203 PLASMA CELL MYELOMA 1 0.0000
204 DRY MOUTH 2 0.0000
205 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
206 RECTAL HAEMORRHAGE 1 0.0000
207 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
208 TACHYCARDIA 2 0.0000
209 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
210 DEPRESSION 5 0.0000
211 NEPHROLITHIASIS 1 0.0000
212 ADVERSE EVENT 2 0.0000
213 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
214 HYPERSENSITIVITY 4 0.0000
215 BLOOD CHOLESTEROL INCREASED 1 0.0000
216 SWELLING 2 0.0000
217 OCULAR HYPERAEMIA 1 0.0000
218 DYSPHAGIA 2 0.0000
219 DISEASE RECURRENCE 1 0.0000
220 PRODUCTIVE COUGH 1 0.0000
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
222 CONTUSION 2 0.0000
223 DRUG INTOLERANCE 2 0.0000
224 SOMNOLENCE 4 0.0000
225 HOSPITALISATION 3 0.0000
226 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
227 RASH PRURITIC 1 0.0000
228 OEDEMA 1 0.0000
229 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
230 URTICARIA 3 0.0000
231 OXYGEN SATURATION DECREASED 1 0.0000
232 FLATULENCE 1 0.0000
233 CONVULSION 1 0.0000
234 SEIZURE 2 0.0000
235 NASAL CONGESTION 1 0.0000
236 JOINT SWELLING 2 0.0000
237 STOMATITIS 1 0.0000
238 CONDITION AGGRAVATED 5 0.0000
239 DISCOMFORT 1 0.0000
240 FEELING HOT 1 0.0000
241 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
242 HYPERHIDROSIS 2 0.0000
243 PRODUCT DOSE OMISSION 1 0.0000
244 BLOOD PRESSURE DECREASED 1 0.0000
245 INJECTION SITE PRURITUS 1 0.0000
246 PRODUCT QUALITY ISSUE 2 0.0000
247 INJECTION SITE REACTION 1 0.0000
248 SLEEP DISORDER 1 0.0000
249 MOBILITY DECREASED 1 0.0000
250 INFECTION 2 0.0000
251 RESPIRATORY FAILURE 1 0.0000
252 EPISTAXIS 1 0.0000
253 HOT FLUSH 1 0.0000
254 DIABETES MELLITUS 1 0.0000
255 INJECTION SITE SWELLING 1 0.0000
256 PRURITUS 5 0.0000
257 PERIPHERAL SWELLING 2 0.0000
258 INJECTION SITE HAEMORRHAGE 1 0.0000
259 INFLUENZA LIKE ILLNESS 1 0.0000
260 ARTHRALGIA 5 0.0000
261 ABDOMINAL DISCOMFORT 2 0.0000
262 MYALGIA 2 0.0000
263 BALANCE DISORDER 1 0.0000
264 PRODUCT STORAGE ERROR 1 0.0000
265 MUSCULOSKELETAL STIFFNESS 1 0.0000
266 HEADACHE 7 0.0000
267 GASTROINTESTINAL DISORDER 1 0.0000
268 SUICIDAL IDEATION 1 0.0000
269 MUSCLE SPASMS 2 0.0000
270 WEIGHT DECREASED 3 0.0000
271 COUGH 3 0.0000
272 ANXIETY 3 0.0000
273 PULMONARY EMBOLISM 1 0.0000
274 MIGRAINE 1 0.0000
275 ATRIAL FIBRILLATION 1 0.0000
276 DYSPEPSIA 1 0.0000
277 FLUSHING 1 0.0000
278 PAIN 6 0.0000
279 ABDOMINAL PAIN UPPER 2 0.0000
280 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
281 ABDOMINAL DISTENSION 1 0.0000
282 HAEMORRHAGE 1 0.0000
283 OVERDOSE 2 0.0000
284 MALAISE 4 0.0000
285 SEPSIS 1 0.0000
286 ASTHMA 1 0.0000
287 MUSCULAR WEAKNESS 1 0.0000
288 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
289 DECREASED APPETITE 2 0.0000
290 BACK PAIN 2 0.0000
291 PALPITATIONS 1 0.0000
292 DISEASE PROGRESSION 1 0.0000
293 OFF LABEL USE 7 0.0000
294 ASTHENIA 3 0.0000
295 DIARRHOEA 5 0.0000
296 DEHYDRATION 1 0.0000
297 NEUTROPENIA 1 0.0000
298 VISION BLURRED 1 0.0000
299 PRODUCT DOSE OMISSION ISSUE 2 0.0000
300 PAIN IN EXTREMITY 2 0.0000
301 BLOOD PRESSURE INCREASED 1 0.0000
302 ACUTE KIDNEY INJURY 1 0.0000
303 FATIGUE 5 0.0000
304 CONFUSIONAL STATE 1 0.0000
305 PNEUMONIA 2 0.0000
306 FALL 2 0.0000
307 CEREBROVASCULAR ACCIDENT 1 0.0000
308 PYREXIA 2 0.0000
309 COVID-19 1 0.0000
310 NASOPHARYNGITIS 1 0.0000
311 CHEST PAIN 1 0.0000
312 BLOOD GLUCOSE INCREASED 1 0.0000
313 ANAEMIA 1 0.0000
314 GAIT DISTURBANCE 1 0.0000
315 ALOPECIA 1 0.0000
316 HYPOTENSION 1 0.0000
317 HYPERTENSION 1 0.0000
318 CONSTIPATION 1 0.0000
319 WEIGHT INCREASED 1 0.0000
320 ABDOMINAL PAIN 1 0.0000
321 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
322 DRUG INEFFECTIVE 5 0.0000
323 NAUSEA 3 0.0000
324 INSOMNIA 1 0.0000
325 DYSPNOEA 2 0.0000
326 INJECTION SITE PAIN 1 0.0000
327 DEATH 2 0.0000
328 VOMITING 1 0.0000